FDA inspection
Mylan Laboratories Limited: FDA inspection ending May 24, 2024
FDA inspection 1238860 · Nasik, Nashik
Key facts
| Inspection ID | 1238860 |
|---|---|
| Firm | Mylan Laboratories Limited |
| FEI number | 3005587313 |
| Address | (FDF-1), F-4 and F-12, Malegaon MIDC, Sinnar |
| City | Nasik, Nashik |
| Fiscal year | 2024 |
| Inspection end date | May 24, 2024 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data